The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BREAKING: FDA UPDATES CATEGORY 2 BULKS LIST OFFICIALLY REMOVES PEPTIDES LIKE BPC 157 The first opportunity for reclassification comes on July 23 24 during the FDA's PCAC meeting Until then, peptides are The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health Beginner's Guide to Peptide Therapy [2026]